These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2946405)

  • 1. Functions of the mos oncogene family and associated gene products.
    Bold RJ; Hannink M; Donoghue DJ
    Cancer Surv; 1986; 5(2):243-55. PubMed ID: 2946405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transformation-resistant mos revertant is unable to activate MAP kinase kinase in response to v-mos or v-raf.
    Topol LZ; Marx M; Calothy G; Blair DG
    Cell Growth Differ; 1995 Jan; 6(1):27-38. PubMed ID: 7718484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A threshold effect in the induction of tumorigenicity of an established human cell line by v-mos.
    O'Hara BM; Blair DG
    Oncogene; 1988 Sep; 3(3):295-9. PubMed ID: 2974527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of v-mos in transformation, oncogenicity, and metastatic potential of mink lung cells.
    Gao CL; Wang LC; Vass WC; Seth A; Chang KS
    Oncogene; 1988 Sep; 3(3):267-73. PubMed ID: 2849740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for interaction between v-Mos and a p34cdc2 isoform, p35cdk.
    Bai W; Singh B; Yang Y; Arlinghaus RB
    Oncogene; 1992 Sep; 7(9):1757-63. PubMed ID: 1323818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of activated and normal mouse Mos gene in murine 3T3 cells.
    Paules RS; Resnick J; Kasenally AB; Ernst MK; Donovan P; Vande Woude GF
    Oncogene; 1992 Dec; 7(12):2489-98. PubMed ID: 1461652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic activation of murine mos protein kinase by DNA rearrangement of its N-terminal coding region.
    Ohuchi T; Kurita Y; Sasai H; Miyoshi J; Nomura T; Toyoshima K
    Oncogene; 1992 Feb; 7(2):331-8. PubMed ID: 1532243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cAMP-independent serine/threonine kinase activity is associated with the mos sequences of ts110 Moloney murine sarcoma virus-encoded P85gag-mos.
    Maxwell SA; Arlinghaus RB
    J Gen Virol; 1985 Oct; 66 ( Pt 10)():2135-46. PubMed ID: 2995551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for somatic cell expression of the c-mos protein [corrected].
    Herzog NK; Ramagli LS; Khorana S; Arlinghaus RB
    Oncogene; 1989 Nov; 4(11):1307-15. PubMed ID: 2530484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single Glu(62)-to-Lys(62) mutation in the Mos residues of the R7Delta447Gag-tMos protein causes the mutant virus to induce brain lesions.
    Yuen PH; Ryan EA; Devroe E; Wong PK
    Oncogene; 2001 Feb; 20(6):692-703. PubMed ID: 11314003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
    Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
    J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The possible role of cellular genes related to retroviruses in the process of chemical and radiation carcinogenesis.
    Weinstein IB; Gattoni-Celli S; Kirschmeier P; Dina D
    Princess Takamatsu Symp; 1982; 12():139-51. PubMed ID: 6897728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common cellular pathway for v-mos and v-Ki-ras is not required for v-Ki-ras-induced tumorigenicity in a nonmalignant, v-mos-expressing revertant cell.
    Gerfaux J; Sergiescu D; Hamelin R; Joret AM; Lallemand C
    Mol Carcinog; 1990; 3(2):103-13. PubMed ID: 2161237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The myb oncogene.
    Lipsick JS; Baluda MA
    Gene Amplif Anal; 1986; 4():73-98. PubMed ID: 3333362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the mouse mammary tumor virus long terminal repeat to promote steroid-inducible expression of v-mos.
    Papkoff J; Ringold GM
    J Virol; 1984 Nov; 52(2):420-30. PubMed ID: 6092668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of v-mos encoded proteins in cells transformed by several related murine sarcoma viruses.
    Papkoff J; Lai MH; Hunter T
    J Cell Biochem; 1982; 19(4):349-62. PubMed ID: 6298255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinase activities of c-Mos and v-Mos proteins: a single amino acid exchange is responsible for constitutive activation of the 124 v-Mos kinase.
    Puls A; Proikas-Cezanne T; Marquardt B; Propst F; Stabel S
    Oncogene; 1995 Feb; 10(4):623-30. PubMed ID: 7862439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability.
    Fukasawa K; Vande Woude GF
    Mol Cell Biol; 1997 Jan; 17(1):506-18. PubMed ID: 8972231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. v-mos protein produced by in vitro translation has protein kinase activity.
    Herzog NK; Nash M; Ramagli LS; Arlinghaus RB
    J Virol; 1990 Jun; 64(6):3093-6. PubMed ID: 2159564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of site-specific antipeptide antibodies to perturb the serine kinase catalytic activity of p37mos.
    Maxwell SA; Arlinghaus RB
    J Virol; 1985 Sep; 55(3):874-6. PubMed ID: 2991608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.